Retrospective analysis was conducted of patients with SRSE who were treated simultaneously with propofol and ketamine. Sixty-seven patients were identified from 2012 to 2015, and outcomes documented were resolution and mortality. The duration of combined ketamine and propofol use ranged from 1 to 28 days (mean - 3.6 days). Infusion rates ranged up to 145 and 175 mcg/kg/min. Vasopressors were used in 53 patients (79%), and were given within the first 5 days of the ICU admission in 48 (91%) patients. The overall SRSE resolution rate was 91%, and the overall mortality including patients with anoxic brain injury was 39%. Of the 13 patients with SRSE as a result of anoxic brain injury, SRSE was controlled in 5 (56%). The primary determinant of mortality was family withdrawing care related to the presence of severe medical/neurological diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.yebeh.2015.07.040 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A case of acute functional hemispherotomy in a young woman with hemimegalencephaly and super-refractory status epilepticus.
Epilepsy Behav Rep
November 2024
Department of Neurology, Oslo University Hospital, Oslo, Norway.
Status epilepticus (SE) is a critical medical emergency that demands immediate and effective intervention. We report a unique case involving a 21-year-old woman with left hemimegalencephaly who was hospitalized for super-refractory status epilepticus (SRSE) that persisted for 8 weeks. Despite extensive treatment efforts including multiple anti-seizure medications, anesthetics, high-dose methylprednisolone, anakinra, magnesium infusion, and a ketogenic diet, her condition remained unchanged.
View Article and Find Full Text PDFKetamine plus midazolam compared to midazolam infusion for the management of refractory status epilepticus.
Clin Neurol Neurosurg
November 2024
Department of Neurology, Thomas Jefferson University Hospital, 901 Walnut Street 4th Floor, Philadelphia, PA 19107, USA. Electronic address:
Article Synopsis
- The study aimed to evaluate the effectiveness of using ketamine along with midazolam for treating refractory and super-refractory status epilepticus compared to using midazolam alone.
- Researchers analyzed data from a neurointensive care unit, identifying two groups of patients: one receiving only midazolam (MDZ cohort) and the other receiving a combination of midazolam and ketamine (Ket+MDZ cohort).
- Results indicated that while the overall time from midazolam start to seizure end was similar for both groups, the Ket+MDZ cohort experienced a significantly shorter time from the start of ketamine infusion to seizure end, suggesting that ketamine may enhance treatment efficacy.
Effects of steroids on super-refractory status epilepticus in tick-borne meningoencephalitis.
Epilepsy Behav Rep
September 2024
Institute for Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
We report a unique case of super-refractory status epilepticus (SRSE) secondary to tick-borne encephalitis (TBE) to evaluate the therapeutic challenges and potential benefits of steroid treatment in this context. A previously healthy 31-year-old woman was admitted to the hospital with fever, headache, vertigo, and meningismus, ultimately diagnosed with TBE. Despite empirical antimicrobial treatment, the patient's condition deteriorated, leading to coma and SRSE.
View Article and Find Full Text PDFMyelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis with super-refractory status epilepticus.
Brain Dev
November 2024
Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.
Article Synopsis
- * A case of a 9-year-old boy revealed that his seizures persisted despite treatment with thiopental, leading to super-refractory status epilepticus; however, seizure control was achieved using continuous ketamine infusion and intrathecal dexamethasone therapy.
- * The patient's diagnosis of MOG-CCE was confirmed with positive ani-MOG antibodies, and after receiving multiple treatments, he remained seizure-free for six months without relapse.*
Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome.
Epilepsy Behav Rep
July 2024
Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.
Article Synopsis
- A 24-year-old woman with refractory epilepsy due to tuberous sclerosis and features of Lennox-Gastaut syndrome was admitted with super-refractory status epilepticus after failed treatments at another clinic.
- Despite two weeks of various treatments, her condition did not improve until Fenfluramin (FFA) was introduced on day 24, initially at 0.7 mg/kg/day.
- Following FFA treatment, both her EEG and clinical condition showed significant improvement, and she remained seizure-free for six weeks, marking a successful application of FFA for her condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!